SCHEMBL2511080

SCHEMBL2511080

O=C(O[C@H]1O[C@H](COC(c2ccccc2)(c2ccccc2)c2ccccc2)[C@@H](OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)[C@@H]1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 8/20 0.49
▸ ANTXR2 P58335 3/20 0.46
▸ F11 P03951 2/20 0.45
▸ USP2 O75604 2/20 0.45
▸ TMPRSS2 O15393 1/20 0.45
▸ PDE5A O76074 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ HMGCR P04035 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ LCK P06239 1/20 0.45
▸ FYN P06241 1/20 0.45
▸ HSPD1 P10809 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CA6 P23280 1/20 0.45
▸ TBXAS1 P24557 1/20 0.45
▸ MAPK3 P27361 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ HSPE1 P61604 1/20 0.45
▸ MAPK14 Q16539 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18241589 0.93 PTPN1 (0.46) PTPN1ANTXR2F11USP2TMPRSS2
SCHEMBL17944054 0.90 PTPN1 (0.45) PTPN1ANTXR2USP2TMPRSS2PDE5A
SCHEMBL8574780 0.89 LGALS9 (0.44) PTPN1ANTXR2USP2TMPRSS2PDE5A
SCHEMBL8576918 0.89 LGALS9 (0.44) PTPN1ANTXR2USP2TMPRSS2PDE5A
SCHEMBL8574777 0.89 LGALS9 (0.44) PTPN1ANTXR2USP2TMPRSS2PDE5A
SCHEMBL17241441 0.88 PTPN1 (0.40) PTPN1ANTXR2F11USP2TMPRSS2
SCHEMBL17241440 0.88 PTPN1 (0.40) PTPN1ANTXR2F11USP2TMPRSS2
SCHEMBL8575225 0.85 PTPN1 (0.41) PTPN1ANTXR2USP2TMPRSS2PDE5A
SCHEMBL8576383 0.85 PTPN1 (0.41) PTPN1ANTXR2USP2TMPRSS2PDE5A
SCHEMBL8577792 0.85 PTPN1 (0.41) PTPN1ANTXR2USP2TMPRSS2PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2205616-B1 NOVEL SULFATED OLIGOSACCHARIDE DERIVATIVES PROGEN PHARMACEUTICALS LTD (AU) 2016-04-27 — — EP disclosed
CN-104666318-A Novel sulfated oligosaccharide derivatives PROGEN PHARMACEUTICALS LTD 2015-06-03 — — CN disclosed
US-20110245196-A1 NOVEL SULFATED OLIGOSACCHARIDE DERIVATIVES PROGEN PG500 SERIES PTY LTD (AU) 2011-10-06 — — US disclosed
EP-2205616-A1 NOVEL SULFATED OLIGOSACCHARIDE DERIVATIVES Progen Pharmaceuticals Limited (AU) 2010-07-14 — — EP disclosed
WO-2009049370-A1 NOVEL SULFATED OLIGOSACCHARIDE DERIVATIVES PROGEN PHARMACEUTICALS LIMITED (AU) 2009-04-23 — — WO disclosed
Send feedback